MetaADEDB 2.0 @ LMMD
Disodium;N-[(6R,7R)-2-carboxy-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-en-7-yl]-3-hydroxy-2-(4-oxidophenyl)-3-oxopropanimidate
(GRIXGZQULWMCLU-HUTAOCTPSA-L)
Structure
SMILES
CO[C@@]1(NC(=O)C(c2ccc(cc2)O)C(=O)[O-])C(=O)N2[C@@H]1OCC(=C2C(=O)[O-])CSc1nnnn1C.[Na+].[Na+]
Molecular Formula:
C20H18N6Na2O9S
Molecular Weight:
564.436
Log P:
-3.4683
Hydrogen Bond Acceptor:
16
Hydrogen Bond Donor:
2
TPSA:
237.26
CAS Number(s):
64953-12-4
Synonym(s)
1.
Disodium;N-[(6R,7R)-2-carboxy-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-en-7-yl]-3-hydroxy-2-(4-oxidophenyl)-3-oxopropanimidate
2.
Moxalactam disodium
External Link(s)
PubChem Compound441242
101821907
CHEMBLCHEMBL1200357
KEGGdr:D02198
Therapeutic Target DatabaseD04VXN
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1EpistaxisCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120289

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.